R
Relmada Therapeutics, Inc. (RLMD)
6.43
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
6.43
0.00 (0.00%)
This stock has a consensus price target of $11.56 based on the ratings of 9 analysts. The high is $26.00 and the low is $1.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 1 | $ 11.56 | $ 26 |
| O’zgarish | -84.45% | 79.78% | 304.35% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-24 | 86.63% | Piper Sandler | $12 | Initiates Coverage On | Overweight |
| 2026-03-20 | 195.49% | Mizuho | $10 → $19 | Maintains | Outperform |
| 2026-03-02 | 117.73% | LUCID CAPITAL MARKETS | $14 | Initiates Coverage On | Buy |
| 2026-01-23 | 24.42% | Leerink Partners | $8 | Upgrades | Market Perform → Outperform |
| 2025-12-22 | 39.97% | Jefferies | $9 | Initiates Coverage On | Buy |